Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs Paclitaxel in HER2-negative Breast Cancer
NCT01705691Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Sep 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by NSABP Foundation. Started Sep 2012; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01705691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705691.